Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Embecta Community
NasdaqGS:EMBC Community
2
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Embecta
Latest
Undervalued
Overvalued
Community Investing Ideas
Embecta
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Debt Reduction And Partnerships Will Strengthen Future Market Position
Key Takeaways Expanding product portfolio and distribution agreements could drive revenue growth through enhanced revenue streams and market diversification. Cost-saving restructuring, debt reduction, and brand transition may enhance financial flexibility, net margins, and global market position.
View narrative
US$20.25
FV
51.4% undervalued
intrinsic discount
-0.033%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
6 days ago
author updated this narrative
Embecta
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Aging And Digital Health Trends Will Open Diabetes Care Opportunities
Key Takeaways Strategic restructuring, innovation investment, and tailored partnerships are expected to accelerate margin expansion, debt reduction, and exposure to high-growth diabetes and GLP-1 markets. Global presence, operational readiness, and strong clinical reputation position the company for robust, sustained growth and improved competitive differentiation.
View narrative
US$25.00
FV
60.6% undervalued
intrinsic discount
0.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
EMBC
EMBC
Embecta
Your Fair Value
US$
Current Price
US$9.84
77.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.1b
Earnings US$54.9m
Advanced
Set Fair Value